Can't find much on it @zmans
Business Model
• Recurring revenues
• Software sold as a service– via software enterprise partners and direct to business – direct to consumers via App Store and Google Play
My first thought is PD is focused on finalising DSA then maybe advertising campaign for Aust, then direct to consumers...
Also looking at the presentation from November it states FDA due in Q1, but the interview with PD after the CR indicated he is not looking at USA until a roll out in Europe has been established...
Who knows!! But it's clear the next 6 months will be full on..
PainChek General Discussion, page-37
-
- There are more pages in this discussion • 20,376 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PCK (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.3¢ |
Change
-0.003(8.33%) |
Mkt cap ! $53.98M | |||
| Open | High | Low | Value | Volume |
| 3.6¢ | 3.6¢ | 3.3¢ | $91.67K | 2.719M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 187734 | 3.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.6¢ | 885331 | 1 |
View Market Depth
| Last trade - 16.10pm 05/09/2024 (20 minute delay) ? |
| PCK (ASX) Chart |